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The infection by human T lymphotropic virus type I is associated with adult T cell leukemia and several inflammatory
degenerative disorders, including tropical spastic paraparesis. To investigate the role of the Tax protein in the development
of diseases linked to human T lymphotropic virus type I infection, we generated two lines of transgenic mice carrying the tax
gene under the control of the viral promoter. The expression of the transgene was low in these mice and was restricted to
the central nervous system and testis. Mice from both lines developed various types of tumors, including fibrosarcomas and
adenocarcinomas. Tax was expressed at a high level in fibrosarcomas and in cell lines derived from these tumors. In
tumor-derived cells, the expression of Tax led to an increased degradation of IkBa and IkBb and caused stable nuclear
translocation of nuclear factor-kB. This translocation was essential for cell proliferation, as shown by expressing a
nondegradable form of IkBb in these cells. Therefore, Tax-induced cell transformation in mice correlates with the degrada-
tion of IkBa and IkBb and with the constitutive activation of NF-kB. © 1998 Academic Press
INTRODUCTION
Human T cell leukemia virus type I (HTLV-I) causes a
variety of diseases, including adult T cell leukemia/lym-
phoma (ATLL) (Hinuma et al., 1981; Poiesz et al., 1980;
Yoshida et al., 1982) and a non-neoplasic inflammatory
neurological syndrome called human T lymphotropic vi-
rus type I (HTLV-I)-associated myelopathy or tropical
spastic paraparesis (HAM/TSP) (Gessain et al., 1985;
Osame et al., 1986). Several other clinical conditions
have been linked to HTLV-I infection on the basis of
seroepidemiological studies; these include uveitis (Mo-
chizuki et al., 1992), Sjo¨gren’s syndrome (Terada et al.,
1994; Vernant et al., 1988), inflammatory arthropathies
(Nishioka et al., 1989), polymyositis (Morgan et al., 1989),
and pneumopathies (Vernant et al., 1988).
The viral protein Tax seems to play a major role in the
pathogenesis of HTLV-I-associated diseases. Tax is
known to stimulate the transcription of viral and cellular
genes such as the genes coding for interleukin 2, inter-
leukin 2 receptor, proto-oncogenes, c-jun and c-fos, sev-
eral cytokines, and MHC molecules (Inoue et al., 1986;
Fujii et al., 1988; Yoshida, 1993). The transforming poten-
tial of Tax has been demonstrated in different experimen-
tal systems. It has been shown that rodent fibroblastic
cell lines expressing Tax form colonies in soft agar and
tumors in nude mice (Tanaka et al., 1990). Also, Tax
transforms primary fibroblasts in cooperation with the
Ras protein (Pozzati et al., 1990) and immortalizes pri-
mary T cells in the presence of interleukin 2 (Grassmann
et al., 1989). In addition, transgenic mice carrying the tax
gene develop different types of tumors (Grossman et al.,
1995; Hinrichs et al., 1987; Nerenberg et al., 1987). Tax
binds directly to DNA but acts in cooperation with sev-
eral cellular transcription factors (Yoshida, 1996); among
these are the serum responsive factor (SRF) (Fujii et al.,
1992), the activating transcription factor/cyclic AMP re-
sponse element binding protein (CREB/ATF) (Bantignies
et al., 1996; Zhao and Giam, 1991), and other members of
the ATF family (Baranger et al., 1995; Perini et al., 1995),
NF-kB-like factors (Ballard et al., 1988; Be´raud et al.,
1994; Munoz et al., 1994; Rousset et al., 1996), and p16INK,
a cell cycle inhibitor (Suzuki et al., 1996). The role of
these different interactions in the cell transformation
mediated by Tax is still unclear. Contradictory findings
have been reported concerning the molecular mecha-
nism of rodent fibroblast transformation. The results of
Smith and Greene (1991) suggest that the CREB/ATF
pathway may play an important role. However, Kitajima
et al. (1992) and Yamaoka et al. (1996) showed that the
activation of NF-kB is essential for Tax-induced transfor-
mation. In a recent report, Matsumoto et al. (1997) sug-
gested that either the NF-kB or the SRF pathways may
operate, depending on the cell type.
The aim of the present work was to study the effects of the
expression of Tax in mice transgenic for the tax gene driven by
an HAM/TSP long terminal repeat (LTR). The mice developed
fibrosarcomas. Because transformation by Tax has been stud-
ied mainly in vitro in cells expressing Tax under the control of
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nonviral promoters, we derived cell lines from these tumors
and investigated the mechanism of transformation of these
lines. We show that the cellular proliferation of these lines is
mediated by the NF-kB/IkB pathway.
RESULTS
Transgenic mice
The tax construct, with minimal flanking plasmid se-
quences (Fig. 1A), was excised by digestion with KpnI/
SpeI, purified, and injected into one-cell embryos of C3H
mice. Two founder animals (Tax I and Tax II) were iden-
tified, and C3H transgenic lines were obtained. In both
lines, PCR analysis of the LTR, tax, and splice site re-
gions (Table 1) gave the expected amplified products
and did not reveal any recombination in the transgene.
The integrity of the transgene was also verified by South-
ern blot analysis after BamHI digestion (data not shown).
The copy number of the transgene in Tax I and Tax II
mice was estimated after hybridization with a tax probe
by comparing the signals obtained, on the same blot, for
DNA from transgenic mice with those from the MT2 cell
line (a chronically infected T cell line containing two
proviral copies per cell). Densitometric analysis showed
that Tax I transgenic animals had 4 or 5 copies of the
transgene, whereas Tax II animals had 8–10 copies (data
not shown). Although homozygous transgenic mice were
obtained recently, the experiments presented in this ar-
ticle were performed on heterozygous animals.
Analysis of transgene expression
Total RNA was extracted from the brain, spinal cord, lung,
kidney, heart, gonads, salivary glands, liver, lymph nodes,
Peyer’s patches, spleen, and thymus of mice from both
transgenic line. Reverse transcription-polymerase chain re-
action (RT-PCR) were performed using total RNA with Tax-
and RT-TG primers (Table 1). Tax mRNA was expressed in
the central nervous system (brain and spinal cord), as well
as in testis (Fig. 1B). RT-PCR analysis for glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) expression was al-
ways positive, demonstrating the integrity of the RNA sam-
ples and the efficacy of RT. Although the transgene was
detected reproducibly by RT-PCR, itcould not be shown
in in situ hybridization or immunocytochemistry, indicat-
ing that the level of expressionwas low.
Development of tumors in transgenic mice
At the age of 6–10 months, various types of tumors
developed in both transgenic lines (Fig. 2A). Most of them
FIG. 1. Structure of the TSP LTR-tax transgene. Expression of the tax
RNA in transgenic mice. (A) Structure of the TSP LTR-tax transgene: tax id
driven by an HTLV-I LTR (U3, R, U5) isolated from a TSP patient. The SV40
splice site and polyadenylation signal are derived from the BamHI frag-
ment of pSVK3 vector. (B) Total RNA from tissues of a Tax I mouse was
subjected to tax specific RT PCR and analyzed by Southern blot hybrid-
ization (the same results were obtained with mice from the Tax II line). (1)
Positive control (DNA extracted from tax transgenic mouse. (2) Negative
control (DNA extracted from a non-transgenic mouse). (C) As a control for
DNA contamination, the PCR was performed on total RNA without RT.
TABLE 1
Primers Used in This Study
Region Name of primers Sequence Size of amplimer
LTR LTR1 59-TCCGGTCGACCATGAGCCCCAAATATCCCCC-39 732 bp
LTR2 59-TCCCAAGCTTAATTTCTCTCCTGAGAGTGCTATAG-39
tax tax 1 59-CTGGCCACCTGTCCAGAGCA-39 268 bp
HTL171 59-TCTGGAAAAGACAGGGTTGGGA-39
targtax 59-CGGCTCAGCTCTACAGTTCC-39
Splice site RTTG1 59-CTGTGGTGTGACATAATTGGAC-39 168 bp (DNA)
RTTG2 59-CCACCACTGCTCCCATTCAT-39 100 bp (RNA)
GAPDH 18 SL 59-CCATGGAGAAGGCTGGGG-39 192 bp
20 SL 59-CAAAGTTGTCATGGATGACC-39
Note. Primers used for screening transgenic mice and for RT-PCR analysis. The expected size of the fragments obtained after amplification with
RT-TG1 and RT-TG2 primers, which flank the splice site present in the transgene, is 168 bp for the amplification of genomic DNA and 100 bp for the
amplification of cDNA.
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were solid tumors of the tail; some were mammary adeno-
carcinomas, hepatocarcinomas, and lung carcinomas. The
incidence of tumors was higher in Tax II mice, suggesting
an effect of the number of copies of the transgene. Approx-
imately 13% (6 of 47) of Tax II mice presented with tumors
of the tail, and ;30% showed weight loss and became
cachectic after 10 months of age. The incidence of mam-
mary carcinomas, hepatocarcinomas, and lung carcinomas
was 6.4% (3 of 47), 2.1% (1 of 47), and 2.1% (1 of 47),
respectively. In comparison, ;5% of the Tax I animals de-
veloped tail tumors, and weight loss was not observed.
Histological examination of the tail tumors revealed elon-
gated, spindle-shaped cells characteristic of a fibrosar-
coma (Fig. 2B). The expression of vimentin in these cells
(Fig. 2C) suggested that they were of mesenchymal origin.
Given their perineural localization, we looked for the ex-
FIG. 2. Characterization of tumors in tax transgenic mice. (A) Macroscopic aspect of mesenchymal tail tumors observed in a Tax II mouse (the same
tumors were observed in mice from the Tax I line). (B) Histological aspect of a tail tumor (T); paraffin-embedded section. (C) Detection of vimentin
in SO/CR tumoral cells by immunoperoxydase. (D) Detection of Po, a Schwann cell-specific marker, by in situ hybridization (arrows). Po is not
expressed in tumor cells (T), indicating that they are not of glial origin. (E) Detection of tax mRNA by in situ hybridization on a paraffin section of a
tail fibrosarcoma, showing that all tumoral cells are positive. (F) Detection of the Tax protein in a tail tumor using immunoperoxidase.
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pression of Po-mRNA, a specific marker of Schwann cells.
Tumoral cells did not express this mRNA, indicating that the
tumors observed in transgenic animals are not schwan-
noma (Fig. 2D). In situ hybridization and immunocytochem-
istry showed a high level of expression of tax mRNA (Fig.
2E) and Tax protein (Fig. 2F) in tail tumors. In contrast, Tax
was not expressed in the other types of tumors found in the
transgenic mice.
Tax expression in cells isolated from tail
fibrosarcomas
We derived cell clones from the tail fibrosarcoma of
Tax II mice to study the role of Tax in tumorigenesis. Five
clones (named SO/CR1 to SO/CR5) were obtained by
limiting dilution and routinely propagating for up to 100
passages. Compared with control untransformed fibro-
blasts, these cells were much more refractile, grew to
higher density, and did not undergo contact inhibition at
confluence. Instead, they formed a large number of foci
after 1 week in culture. All SO/CR clones were vimentin1,
Po2, Mac12, F4/802, Class I1, and Class II2 as indi-
cated by immunocytochemistry and FACS analysis (data
not shown). They all expressed high levels of Tax protein
as shown by Western blotting (Fig. 3). In situ hybridization
and immunocytochemistry confirmed the presence of
high levels of tax mRNA and protein expression, respec-
tively (Figs. 4A and 4B). Primary fibroblasts derived from
nontumoral tail tissue of transgenic mice were negative
for the expression of Tax, including by RT-PCR. The
tumorigenicity of one clone (SO/CR2) was tested in C3H
and BALB/c nude mice. The subcutaneous inoculation of
106 cells in BALB/c nude mice and 5 3 106 cells in
FIG. 3. Western blot analysis of Tax protein in tumoral cell lines. Total
cell extracts were performed to analyze Tax expression in cell lines.
(Lane 1) Primary fibroblasts from a nontransgenic C3H mouse. (Lane 2)
Primary nontumoral fibroblasts from a Tax transgenic mouse. (Lane 3)
L929 mouse fibroblastic cells. (Lanes 4 and 5) SO/CR 2 and SO/CR4
cells.
FIG. 4. Characterization and tumorigenic capacity of SO/CR2 cells. (A) tax mRNA detection by in situ hybridization in SO/CR cells. (B) Tax protein
detection by immunoperoxidase in SO/CR cells. (C) Fibroblastic tumors in a 2-month-old nude Balb/c mouse, 10 days after subcutaneous injection
of 106 SO/CR2 cells. (D) Tumor in a 2-month-old C3H mouse, 10 days after subcutaneous injection of 5 3 106 SO/CR2 cells.
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6-week-old C3H mice induced fibroblastic tumors (1 cm
diameter) as early as 1 week after inoculation (Figs. 4C
and 4D). To examine the possibility that mutations in the
transgene were responsible for the tumors observed in
the Tax II and Tax I cell lines, we used PCR for amplifi-
cation and sequenced the transgene from a tail biopsy of
a transgenic mouse and from the SO/CR2 cell line. The
sequences were identical to that of the initial tax trans-
gene.
p53 and p16 status in SO/CR clones
The level of Tax expression was similar in all SO/CR
clones. Therefore, all experiments described in the rest
of this article were performed in parallel on two clones
taken at random, SO/CR2 and SO/CR4.
It has been shown that a mutated form of the tumor
suppressor p53 accumulates in the nucleus of PBMC
transformed by HTLV-I (Reid et al., 1993; Yamato et al.,
1993). However, we did not detect an accumulation of the
p53 protein by western blot analysis in SO/CR clones
compared to the MT2 cell line (data not shown).
It has been suggested that the binding of Tax to p16
could be responsible for cell transformation. Therefore
p16 expression was analyzed by western blot on primary
fibroblasts, SO/CR clones and spleen lymphocytes (as
positive control). The expression of p16 was high in
mouse lymphocytes but no expression was observed in
primary fibroblasts or SO/CR clones (data not shown).
Therefore, binding of Tax to p16 is not responsible for the
SO/CR cell lines transformation.
NF-kB activation of SO/CR cells
It also has been suggested that Tax transforms cells
by activating NF-kB; therefore, we examined the effect of
Tax expression on the nuclear translocation of NF-kB in
SO/CR clones. A plasmid containing the thymidine ki-
nase (TK) promoter, 3 consensus NF-kB functional sites
and the luciferase gene (3NF plasmid) was transfected in
SO/CR clones and control cells (Fig. 5A). The same
construction in which the NF-kB sites had been mutated
(M6 plasmid) also was transfected as a control. After
transfection with these plasmids, the luciferase activity is
either NF-kB dependent (3NF plasmid) or independent
(M6 plasmid). The expression due to NF-kB can be
measured as the ratio of the luciferase activity obtained
with the 3NF and M6 plasmids. The results presented in
Figure 5A show that the NF-kB-specific luciferase activity
is 6–11 times higher in SO/CR clones than in control
cells.
Nuclear cell extracts were prepared from SO/CR
clones as well as from C3H primary fibroblasts and NIH
3T3 cells. The binding of proteins to an oligonucleotide
containing a consensus NF-kB site was tested in these
extracts using an electrophoretic mobility shift assay
(EMSA) (Fig. 5B). The specificity of the binding assay for
the NF-kB factors was tested by competition with an
OCT-1 consensus oligonucleotide. A high level of NF-kB
binding activity was observed in SO/CR clones com-
pared with control cells. These results clearly indicate
that stable Tax expression induces a constitutive level of
nuclear NF-kB DNA binding activity in the absence of
FIG. 5. Analysis of NF-kB nuclear translocation in SO/CR clones. (A)
Luciferase activity measured in SO/CR and control cells after transfec-
tion with the 3NF or the M6 plasmids. Luciferase activity was measured
36 h after transfection, and the ratios of the activities obtained with the
3NF and M6 plasmids were calculated. (B) Gel shift analysis for NF-kB
proteins performed with 2.5 mg of nuclear extract and a 32P-labeled
oligonucleotide containing a consensus NF-kB site. Binding competi-
tions were carried out by preincubating the nuclear extracts with either
1.75 pmol of nonlabeled oligonucleotide corresponding to an NF-kB
site (specific competition) or an OCT-1 site (nonspecific competition).
(Lane 1) Primary tail fibroblasts. (Lane 2) 3T3 cells. (Lanes 3 and 4)
SO/CR2 and SO/CR4 cells. (Lanes 5 and 6) The same SO/CR cells
pretreated during 5 h with 250 ng/ml calcium ionophore and 50 ng/ml
PMA. (Lane 7) Nonspecific binding competition performed with a cold
oligonucleotide corresponding to an OCT-1 site. (Lane 8) Specific
competition with an oligonucleotide corresponding to an NF-kB site.
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induction with molecules such as phorbol-12-myristate-
13-acetate (PMA) or calcium ionophore.
Tax-induced nuclear translocation of NF-kB is due to
the degradation of IkB
The nuclear translocation of NF-kB factors is regulated
by IkB molecules. On cell activation by phorbol esters,
mitogens, or cytokines, IkB molecules are phosphory-
lated and subsequently degraded by proteasomes. This
leads to a rapid translocation of the active NF-kB com-
plex into the nucleus. Therefore, the activation of NF-kB
observed in SO/CR clones could be due to the degrada-
tion of IkB. We examined this possibility by measuring
the level of IkB molecules before and after treatment with
the proteasome inhibitor N-benzyloxycarbonyl-leucyl-
leucyl-leucinal (MG-132; synthesized by the Organic
Chemistry Laboratory, Institut Pasteur, Paris, France).
Cells were treated with 20 mM MG-132 and lysed after 1,
2, or 5.5 h of treatment, and IkB molecules were detected
by Western blotting using specific antibodies against
IkBa and IkBb. In the absence of inhibitor, no IkBa and
only small amounts of IkBb were observed in SO/CR
clones. The amount of both IkBa and IkBb increased
with time during treatment with MG-132 (Fig. 6). In con-
trast, both factors could be easily detected in control
primary fibroblasts, even without treatment with the pro-
teasome inhibitor. Their levels did not increase with
MG-132 treatment. This result indicates that the IkBa
and IkBb proteins are constitutively degraded by protea-
somes in Tax-transformed SO/CR clones.
The nuclear translocation of NF-kB is essential
for transformation
To determine the role of NF-kB translocation in the
transformation of SO/CR clones, we stably expressed in
these cells a transdominant mutant of IkBb molecule.
This mutant cannot be degraded because of two point
mutations in crucial phosphorylation sites (Ser193 Ala,
and Ser23 3 Ala). The expression of this mutant irre-
versibly blocks the nuclear transfer of NF-kB (Weil et al.,
1997). If the transformation of SO/CR clones is due to the
nuclear translocation of NF-kB, the expression of this
mutant IkBb molecule should cause a loss of their trans-
formed phenotype. Because SO/CR clones could not be
transfected efficiently by usual procedures (as deter-
mined with a plasmid expressing b-galactosidase), we
infected the cells with a nonreplicative murine retrovirus
expressing the mutated IkBb gene. The preparation of
this retroviral vector, derived from vector pLXSN, is de-
scribed in Materials and Methods. SO/CR clones and
control NIH 3T3 and L929 cells were infected with 5-fold
dilutions of the supernatant of transfected packaging
cells and allowed to grow in the presence of neomycin.
Two weeks after infection, G418-resistant clones were
counted. The data presented in Table 2 show that the
expression of the mutated IkBb did not affect the prolif-
eration of the control cells. In contrast, the number of
clones of SO/CR cells was drastically reduced by the
expression of the IkBb mutant (Table 2, Fig. 7). The few
colonies obtained after infection of SO/CR clones by the
IkBb mutant vector were much smaller than those grow-
ing in controls, indicating inefficient growth. Their pres-
ence might be due to residual endogenous IkBb activity
despite the presence of the transdominant mutant.
To verify that the level of expression of the transdomi-
nant mutant was the same in control cells and the SO/CR
clones, we infected these cells at a high m.o.i. with the
retrovirus expressing the mutated IkBb gene. At 24 h
after infection, we measured the level of the mutated
IkBb by Western blot analysis, using an antibody specific
for the HA tag present in the mutated IkBb construct. The
mutated IkBb gene was expressed at comparable levels
in SO/CR clones and in nontransformed primary fibro-
blasts (data not shown). As a separate control, another
retroviral recombinant was constructed by incorporating
the lacZ gene, instead of the mutant IkBb gene, in the
pLXSN vector. After infection with this vector, the level of
b-galactosidase activity was the same in control cells
and in the SO/CR clones.
Taken together, our results show that the SO/CR
clones cannot proliferate in the absence of degradation
of IkBb and indicate that the nuclear translocation of
NF-kB may be critical for Tax-mediated transformation.
TABLE 2
Effects of Mutated IkBb on Tax-Induced Cell Proliferation
NIH 3T3 L929 SO/CR2 SO/CR4
pLXSN vector 1525 2060 370 315
pLXSN vector containing
mutated IkBb 1450 1975 32 44
Ratio 1:1 1:0 11:6 7:2
Note. Number of G418 resistant clones obtained after infection of
SO/CR and control cells by a retroviral vector (see Fig. 7). The ratio of
the number of clones obtained with pLXSN control vector and pLXSN-
A19-A23-IkBb infection gives a quantitative estimation of the effect of
NF-kB activity on cell viability and cell proliferation.
FIG. 6. Degradation of IkB molecules in SO/CR cells. Western blot
analysis of cells treated with MG-132 reveals the accumulation of IkBa
and IkBb molecules in SO/CR cells. Treatment was performed with 20
mM of MG-132 for 1, 2, and 5.5 h of incubation. Lane 0 represents cell
extracts without MG-132 treatment. Primary fibroblasts were used as
control cells.
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Interestingly, our results also show that the proliferation
of L929 and NIH 3T3 cells does not require the NF-kB
pathway.
DISCUSSION
In this work, we describe mice transgenic for the
HTLV-I tax gene under the control of an HTLV-I LTR
obtained from a patient with HAM/TSP. The expression of
the transgene was detected mainly in the central ner-
vous system, in the brain as well as the spinal cord, and
in testis. No neurological pathology was observed in
these transgenic mice. The same expression profile was
observed in two different transgenic lines, indicating that
the number of copies of the transgene and the integra-
tion site were not responsible for this pattern.
It has been suggested that the LTR of HTLV-I might
contain determinants of pathogenicity. At present, our ob-
servations speak against this idea. In a previous work, we
observed the same expression pattern as that described in
the present work in mice transgenic for the LacZ gene
under the control of HTLV-I promoters originating from pa-
tients with ATL or HAM/TSP (Coscoy et al., 1996). The mice
had a DBA/2xC57B1/6 genetic background, whereas in the
present work, the transgenic mice were inbred C3H. Thus,
the genetic background of the mice, the nature of the
reporter gene, and the origin of the LTR had no influence on
the expression pattern driven by HTLV-I LTRs. In another
work, we compared the in vitro promoter activity of LTRs
isolated from patients with ATL or HAM/TSP and showed
that although the activities were statistically different in
some of the cell lines tested, there was no correlation
between promoter activity and the disease from which the
LTR was obtained (Gonzalez-Dunia et al., 1993). Further-
more, despite the fact that the promoter used in the present
work was derived from a patient with HAM/TSP (Evange-
lista et al., 1990), the transgenic mice developed tumors,
just as did mice transgenic for the tax gene with an HTLV-I
promoter obtained from a patient with ATL (Nerenberg et
al., 1987). Therefore, contrary to the suggestion made by Xu
et al. (1996), all our observations argue against the pres-
ence of disease-specific determinants in the HTLV-I LTR.
Several studies using transgenic mice have been per-
formed to understand the role of Tax in HTLV-I pathogen-
esis. These studies used various promoters to control
the tax gene: the human granzyme B promoter (Gross-
man et al., 1995), the metallothionein promoter (Saggioro
et al., 1997), and the Thy-1 promoter (Nerenberg et al.,
1991). The mechanism of Tax-induced transformation
has also been studied in vitro in cells transfected with
the tax gene under the control of various promoters
(Smith and Greene, 1991; Yamaoka et al., 1996). In con-
trast, we studied the in vivo transformation mediated by
Tax expressed under the control of its own promoter.
It is now established that Tax interacts with multiple
cellular proteins (Yoshida, 1996). However, the events
responsible for cell transformation have not yet been
clearly identified. Although results often are contradic-
tory, several authors suggested that the expression of
NF-kB is necessary for the maintenance of the malignant
phenotype in Tax-transformed fibroblasts (Kitajima et al.,
1992; Yamaoka et al., 1996). Our results indicate that the
constitutive expression of Tax leads to a continuous
activation of NF-kB in tumor-derived murine cells. We
showed that this activated results from an increased
degradation of both IkBa and IkBb and that blocking this
degradation stops the proliferation of the cells. Interest-
ingly, an increased degradation of IkBa has been de-
scribed in T cells of patients with ATL (Kanno et al., 1994;
Lacoste et al., 1995).
We also investigated the involvement of p16 in Tax-
induced transformation. We did not detect p16 expres-
sion in primary fibroblasts and in the SO/CR2 and SO/
CR4 cell lines, indicating that in our model, this negative
regulator of the cell cycle does not play a role in cell
transformation. It has also been shown that a mutated
FIG. 7. Expression of a mutated IkBb in Tax-transformed cells leads
to a reversal of the transformed phenotype. Neomycin resistant clones
of L929, SO/CR2 and SO/CR4 cells were obtained by infection with a
recombinant retrovirus. (Column A) Infection with the control recombi-
nant vector. (Column B) Infection by a recombinant vector expressing
the mutated IkBb protein. (Row 1) L929 cells. (Row 2) SO/CR2 clone.
(Row 3) SO/CR4 clone.
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form of the tumor suppressor p53 accumulates in the
nucleus of peripheral blood mononuclear cells trans-
formed by HTLV-I (Reid et al., 1993; Yamato et al., 1993).
We examined p53 levels in SO/CR2 and SO/CR4 cells.
No stabilization or increased amounts of p53 protein
were observed by Western blotting in these cells com-
pared with the MT2 cell line.
In conclusion, we set up a system in which the differ-
ent factors involved in the transformation by Tax can be
studied easily. This system allowed us to demonstrate
that the Tax-induced transformation of mice fibroblasts is
mediated by the degradation of IkB factor.
MATERIALS AND METHODS
Cell culture
NIH 3T3 and L929 cells were purchased from Ameri-
can Type Culture Collection (Rockville, Maryland).
FLYRD18 cells (Cosset et al., 1995) were kindly provided
by J.-M. Heard (Institut Pasteur). Tumoral SO/CR clones
were derived from the tail fibrosarcoma of a Tax II trans-
genic mouse. Tail tumors were removed and trypsinized
with gentle shaking at 37°C. Clones were obtained by
limiting dilution. These cells were propagated for up to
100 passages. As a control, nontumoral primary fibro-
blasts were derived from the tails of newborn nontrans-
genic C3H mice. These cells could not be propagated
more than five to eight passages. All cells were main-
tained in Dulbecco’s modified Eagle’s medium with Glu-
tamax II (GIBCO BRL, Grand Island, New York), supple-
mented with 10% fetal calf serum and antibiotics. The
MT2 cell line was obtained from the National Institutes of
Health AIDS Research and Reference Reagents Pro-
gram.
Plasmids
To obtain the transgene described in Figure 1, the viral
LTR was amplified by PCR from peripheral blood lym-
phocytes of a patient with TSP/HAM and cloned in pBlue-
Script SK. A cDNA coding for Tax (Gonzalez-Dunia et al.,
1992) was inserted downstream from the LTR. The SV40
splice site and polyadenylation signal derived from
pSVK3 were cloned at the 39 end of the construct as
described (Coscoy et al., 1996). Plasmids expressing the
luciferase gene driven by the TK promoter (3NF and M6)
were kindly provided by F. Bachelerie (Institut Pasteur).
Plasmid 3NF contains three consensus NF-kB sites
downstream of the promoter. These sites are mutated in
the M6 plasmid, abolishing the binding of NF-kB factors.
The transdominant mutant of IkBb was excised from
pRc-CMV-(A19-A23)-IkBb plasmid (Weil et al., 1997) by
HindIII/XbaI digestion and subcloned in a pBlueScript
(SK) vector. This plasmid was then digested by XhoI, and
the insert was cloned in the pLXSN retroviral vector,
kindly provided by J.-M. Heard (Institut Pasteur). In the
resulting plasmid, named pLXSN9-(A19-A23)-IkBb, the
transdominant mutant of IkBb is expressed under the
control of the MuLV LTR. This vector also confers resis-
tance to neomycin.
Production of a retroviral vector containing IkBb
mutant
On transfection with pLXSN vector, packaging of the
FlyRD18 cell line produces nonreplicative viral particles,
which can be used for stable gene transfer and expres-
sion (Cosset et al., 1995). For transfection, FLYRD18 cells
were electroporated (1000 V, 25 F) in cold PBS with 10 mg
of pLXSN or pLXSN-(A19-A23)-IkBb plasmids using Bio-
Rad (Hercules, CA)GenePulse. Virus-containing super-
natants were harvested 48 h post-transfection, diluted
with Polybrene (8 mg/ml), and used to infect 2.5 3 105
target cells. After 8 h, the inoculum was replaced by fresh
medium; 16 h later, 1 mg/ml G418 was added. Two weeks
later, the cells were fixed with 10% formaldehyde for 10
min and stained with crystal violet, and G418-resistant
clones were counted.
Transgenic mice
Manipulation of mice and eggs were carried out in the
transgenesis laboratory at the Pasteur Institute using
standard procedures. The LTR-tax transgenic mice were
generated in an inbred C3H background. The DNA con-
struct was linearized and purified before microinjection
in fertilized C3H eggs. Founder animals were identified
by PCR on DNA from tail biopsies, using LTR and tax-
specific primers (Table 1). The LTR-tax founders were
mated with C3H mice, and transgenic animals were
screened by PCR analysis of DNA from tail biopsies.
RNA purification and RT-PCR
Mice were anesthetized and perfused with PBS to
avoid blood contamination. Organs were collected and
RNA was purified according to the GAPC method (Chom-
czynski and Sacchi, 1987), treated with RQ1 DNase, and
reverse transcribed by the AMV reverse transcriptase as
described previously (Coscoy et al., 1996). Primers used
for PCR are shown in Table 1. Amplified products were
detected by Southern blot hybridization using [32P] 39
end-labeled specific oligonucleotide probes.
Histochemical analysis
Mice were anesthetized and perfused with 25 ml of
PBS followed by 25 ml of 4% paraformaldehyde (PFA).
The organs were fixed in 4% PFA, embedded in paraffin,
and processed by standard histological procedures. In
situ hybridization was performed as previously described
(Brahic and Ozden, 1992; Ozden et al., 1991) using 35S-
labeled riboprobes specific for Tax or Po-mRNA, a spe-
cific marker for Schwann cells.
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Immunoblotting
Exponentially growing cells were lysed in 150 mM
NaCl, 50 mM Tris, pH 8, 1% Nonidet P-40, 0.5 mM phe-
nylmethylsulfonyl fluoride, and 0.2 mg/ml Pefabloc (Inter-
biotech/Interchim, Montluc˛on, France). Chromatin was
removed by centrifugation for 5 min at 13,000 g. Protein
concentration was determined by the BCA protein assay
(Pierce Chemical, Rockford, Illinois). Proteins (50 mg)
were fractionated by SDS–PAGE, transferred to a cellu-
lose membrane, incubated with an anti-Tax monoclonal
antibody (168A51; National Institutes of Health AIDS Re-
search and Reference Reagents Program) and then with
an anti-mouse horseradish peroxidase-coupled IgG and
detected with a chemiluminescence detection kit (Amer-
sham). Mouse anti-IkBa, rabbit anti-IkBb, mouse anti-
p53 antibodies, and a mouse anti-HA (a tag present in
the mutant IkBb) were provided by F. Arenzana, R. Weil,
F. Thierry, and C. Muchardt, respectively (Institut Pasteur,
Paris). Monoclonal antibodies (sc-1661 and sc-099) from
Santa Cruz (Santa Cruz, California) were used to detect
mouse p16 and p53 proteins.
Luciferase activity assay
SO/CR and control cells (5 3 105 cells) were trans-
fected with 1 mg of plasmid using Lipofectamine as
described by the manufacturer (Life Technologies, Grand
Island, New York). Cells were harvested 36 h post-trans-
fection and lysed in 25 mM Tris, pH 7.8, 8 mM MgCl2, 1
mM dithiothreitol, 1% Triton X-100, 1% bovine serum al-
bumin, and 15% Glycerol. Luciferase activity was deter-
mined with a Lumat LB9501 luminometer (Berthold,
France) using 1 mM ATP and 0.25 mM D-luciferin (Sigma
Chemical, St. Louis, Missouri) as a substrate.
EMSA
Exponentially growing cells were washed in PBS and
treated with 50 mM NaCl, 50 mM HEPES, pH 8, 500 mM
sucrose, 1 mM EDTA, 0.5 mM spermidine, 0.2% Triton
X-100, 0.5 mM phenylmethylsulfonyl fluoride, and 0.2
mg/ml Pefabloc. After centrifugation, the pellets were
washed in 50 mM NaCl, 10 mM HEPES, pH 8, 25%
glycerol, 0.1 mM EDTA, 0.5 mM spermidine, and 0.15 mM
spermine and then resuspended in 350 mM NaCl, 10 mM
HEPES, pH 8, 25% glycerol, 0.1 mM EDTA, 0.5 mM sper-
midine, and 0.15 mM spermine. After centrifugation, su-
pernatants were used as nuclear extract for DNA binding
reactions using a gel shift assay system from Promega
(Madison, Wisconsin). Gel shift analysis of NF-kB pro-
teins were performed with 2.5 mg of nuclear extract using
32P-labeled oligonucleotide containing a consensus
NF-kB site. Competitions were carried out by preincu-
bating extracts (for 20 min on ice) with 1.75 pmol of
nonlabeled oligonucleotides corresponding either to the
NF-kB site (specific competition) or the OCT-1 site (non-
specific competition). The NF-kB consensus double-
stranded oligonucleotide sequence was 59-AGTTGAGG-
GGACTTTCCCAGGC-39 and the OCT-1 consensus dou-
ble-stranded oligonucleotide was 59-TGTCGAATGCAAA-
TCACTAGAA-39. After incubation with the 32P-labeled
probe (30 min at 37°C), nuclear extracts were loaded
onto 5% nondenaturing polyacrylamide gels and run in a
0.53 Tris-borate EDTA buffer.
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